Peer Review History
| Original SubmissionJuly 23, 2022 |
|---|
|
PONE-D-22-20174Will R&D make investors more tolerant? Analysis based on the performance forecast of Chinese listed companiesPLOS ONE Dear Dr. Xu, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Nov 06 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Maurizio Fiaschetti Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ 3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. Additional Editor Comments: The reviewers have raised some good point, therefore I would encourage you to address all of them thoroughly. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This paper explores the impact of corporate R&D on investors' short-term performance expectations by analyzing listed companies that disclosed quantitative performance forecasts from 2016 to 2021 in the Shanghai and Shenzhen A-share markets. The results suggest that corporate R&D investment significantly reduces investors' short-term performance expectations that is, investors have a significant tolerance effect on enterprises with higher R&D investment. I believe that the paper needs improve argument development, formal alterations and more work to be done before publication in this reputed journal. Major Points: • It is not clear what is the problem at hand. How this work differs from the previous work done in this area? It needs sharp contextualization. • This paper takes all A-share listed companies that disclosed their performance forecasts from 2016 to 2021 as samples. Contextualization from the context of sample firms and the country is missing. Why do authors rely on Chinese firms only? The authors should add a paragraph on the dynamics and importance of focusing on this sample. • Make the literature section comparable that how your work is superior to previous work. Also, no theoretical underpinnings are provided in the literature section and empirical literature included in the paper does not cover recent evidence. • The study applied a multiple regression model to analyse the data. How it is well suited for achieving the study’s objectives. The authors should add a significant justification for why you picked this estimation model. • It is good that the authors have employed robustness analysis with different models and measurements of variables. However, the economic significance and discussion of the main results as well as of the robustness analysis is missing. The findings and discussion section does not provide the needed explanation and support from previous studies. The key findings should be compared with the existing studies, and they should highlight whether these findings are consistent or the other way around. • Also, I encourage authors to develop the practical implications specifically based on the findings of the study instead of general discussion. Authors need to be more specific when it comes to possible future extensions of their work. • There are grammatical mistakes in the paper. Please carefully go through the paper for in-text citation errors, spelling and grammatical mistakes before submitting the revised version. Reviewer #2: The topic of the manuscript is interesting. Studying the behavior of investors and the factors that influence this behavior is important in terms of identifying barriers to economic development. However, the manuscript could be improved, my comments are attached: - it is necessary to clarify the research methods used in the abstract, also describe the general conclusion based on the results (in the context of significance) - it is recommended to revise the structure of the Introduction, focusing on a consistent description of the relevance, scientific and practical problems, bright points of view on this problem (other studies) with a transition to the purpose of the study and tasks, study design. The authors also need to clarify the choice of China as a field for empirical research (in terms of relevance and the possibility of applying the results to other countries) - section 2.3 Research hypotheses is closer to 3. Methodology than to 2. Literature review - authors are advised to separate the Discussion section and the Conclusions section, therefore section 5 needs to be revised - a clear clarification of research limitations and assumptions is required (including making a reasonable conclusion about the possibility of extrapolating the results for other countries, and not just for China) - the data file could be improved for reader accessibility (use English). It is recommended to add notes for headings with symbols; also add sheet descriptions and sheet titles. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Prof. Ahmed Imran Hunjra Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-22-20174R1Will R&D make investors more tolerant? Analysis based on the performance forecast of Chinese listed companiesPLOS ONE Dear Dr. Xu, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jan 18 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Maurizio Fiaschetti Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Your paper is well strucutred and written and it adds a valuable contribution to the debate. Reviewer 2 has some minor issues I would strongly encourage you to quickly address before resubmitting your work. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: I Don't Know Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: The authors did a great job and provided a revised manuscript, taking into account the comments of the reviewers. However, there are a few items that could be improved (minor revision): - In Section 2.3, the authors gave a description of the H1 hypothesis, but did not provide a description of the H2 hypothesis. - Authors need to provide links to sources of primary data. In section 3.1, the authors provide data resources, but no references. - Authors are advised to clarify the sample size. "This paper takes all A-share listed companies that disclosed their performance forecasts from 2016 to 2021 as samples." How many such companies? - Since a sample has some specific characteristics that determine its quality, researchers may be interested in the question of the coverage of the dissemination of the results. The authors are advised to briefly clarify the representativeness of the results (through reliability indicators, calculation of sampling error, etc., if applicable in this case). Reviewer #3: This is an interesting paper. All suggestions are carefully fixed and I recommend to publish this interesting paper. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Will R&D make investors more tolerant? Analysis based on the performance forecast of Chinese listed companies PONE-D-22-20174R2 Dear Dr. Xu, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements and you fix those minor issues flagged up by two reviewers. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Maurizio Fiaschetti Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed Reviewer #4: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: Minor fixes. -Numbering of sections is broken (2.2, 2.3, 2.3) -The description of the hypothesis H2 is very short (compared to the description of the hypothesis H1) Reviewer #3: All suggestions are carefully addressed and I am glad to recommend to publish this interesting paper. Reviewer #4: Summary This paper investigates the impact of Chinese listed companies R&D investments on investors’ short-term performance expectations, through adopting event study method to obtain the market reaction of performance forecasts. The authors find that corporate R&D investments help to reduce the investors’ short-term performance expectations and the investors show more tolerance to the corporates with high R&D investments. Moreover, institutional investors shareholdings have negative impact on the tolerance effect and the implementation of China’s innovation-driven strategy promotes the tolerance effect and thus corporate innovation. Comments 1. The references with high quality cited in this paper are far from sufficient and supportive as present, especially for identifying the investors’ short-term performance expectations. In this paper, it is a key point to find an appropriate proxy variable for the investors’ expectations, which are usually discussed in theoretical model in the extant literature. It is required a convincing explanation with literature supporting for illustrating the validity and accuracy of the identification method in empirical analysis. 2. Combined with Chinese institutional and regulation background, generally, corporates with material performance change or considerable loss are required to release performance forecasts compulsively. That is to say, the sample companies are likely to have unstable cash flow and stock price, leading to the prominence of short-term holding speculation rather than long-term investment. Besides, Heckman model shows the existence of sample selection bias, which need to be addressed more prudentially and thoroughly. 3. As the control variables are limited relatively, firm fixed effect is suggested to adopt in regression to mitigate the endogeneity problem of omitting variables. 4. There is a lack of definition and introduction of the variable 〖URF〗_it in the regression. Reference Adcock, C., Hua, X., Mazouz, K., & Yin, S. (2014). Does the stock market reward innovation? European stock index reaction to negative news during the global financial crisis. Journal of International Money and Finance, 49(Part B), 470–491. Chan, L. K. C., Lakonishok, J., & Sougiannis, T. (2001). The Stock Market Valuation of Research and Development Expenditures. Journal of Finance, 56(6), 2431–2456. David, D. , & Paolo, F. . (2020). Uncertainty, investor sentiment, and innovation. The Review of Financial Studies(3), 3. Howell, S. T. (2017). Financing Innovation: Evidence from R&D Grants. American Economic Review, 107(4), 1136–1164. Oh, J.-M. (2017). Absorptive Capacity, Technology Spillovers, and the Cross-Section of Stock Returns. Journal of Banking and Finance, 85, 146–164. Song, J., Su, Z., & Nie, X. (2018). Does development of financial markets help firm innovation? Evidence from China. Economic & Political Studies, 6(2), 194–208. Wu, Q., Zheng, L., & Hasan, T. (2022). CEOs’ political ideologies and innovation: Evidence from US public firms. Economic & Political Studies, 10(3), 353–367. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No Reviewer #3: No Reviewer #4: No ********** |
| Formally Accepted |
|
PONE-D-22-20174R2 Will R&D make investors more tolerant? Analysis based on the performance forecast of Chinese listed companies Dear Dr. Xu: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Maurizio Fiaschetti Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .